Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

La Jolla Pharmaceutical submits IND to the FDA for LJPC-501

June 5, 2013

Otsuka files application in Japan for tolvaptan in autosomal dominant polycystic kidney disease

June 3, 2013

Targacept reports commencement of phase IIb TC-5214 study

May 31, 2013

Data show GCS-100 may improve renal function

May 27, 2013

Netherlands first to approve Vesomni

May 23, 2013

Dosing completed in phase I TTI-1612 study

May 17, 2013

Mirabegron/solifenacin as an effective therapeutic option for overactive bladder

May 16, 2013

Fedovapagon effectively reduces nocturia in men with BPH

May 15, 2013

Relypsa completes enrollment in pivotal phase III trial of patiromer

May 14, 2013

Astellas and Drais form new partnership to develop treatment candidate for nocturia

May 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...